DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Net Current Assets History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹8,629 Cr | ₹8,397 Cr | ₹8,211 Cr | ₹7,156 Cr | ₹5,062 Cr |
What is the latest Net Current Assets ratio of DIVIS LABORATORIES ?
Year | Net Current Assets |
---|---|
Mar2025 | ₹8,629 Cr |
Mar2024 | ₹8,397 Cr |
Mar2023 | ₹8,211 Cr |
Mar2022 | ₹7,156 Cr |
Mar2021 | ₹5,062 Cr |
How is Net Current Assets of DIVIS LABORATORIES Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2025 | ₹8,629 Cr | 2.76 | |
Mar2024 | ₹8,397 Cr | 2.27 | |
Mar2023 | ₹8,211 Cr | 14.74 | |
Mar2022 | ₹7,156 Cr | 41.36 | |
Mar2021 | ₹5,062 Cr | - |
Compare Net Current Assets of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹162,014.7 Cr | 1.3% | 0.3% | 10.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹395,626.0 Cr | 2% | 1.4% | -13% | Stock Analytics | |
CIPLA | ₹127,494.0 Cr | 0.3% | 1.9% | -6.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,718.0 Cr | 0% | -2.3% | 2.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,374.0 Cr | 0.5% | 6.2% | -1.4% | Stock Analytics | |
MANKIND PHARMA | ₹108,892.0 Cr | 2.3% | 5.9% | 4.6% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | 1.3% |
0.3% |
10.4% |
SENSEX | 1.8% |
2.1% |
0.2% |
You may also like the below Video Courses